Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)

被引：3
作者：
Menon, Lalitha L. [1 ]
Chin, Beatrice [1 ]
Khattak, Muhammad A. [1 ,2 ,3 ]
机构：
[1] Fiona Stanley Hosp, Dept Oncol, Perth, WA, Australia
[2] Univ Western Australia, Dept Med Oncol, Perth, WA, Australia
[3] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2018年 / 48卷 / 12期
关键词：
D O I：
10.1111/imj.14131
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1542 / 1543
页数：2
相关论文
共 50 条
  • [41] Ledipasvir/Sofosbuvir With Ribavirin for the Treatment of Fibrosing Cholestatic Hepatitis C After Liver Transplantation
    Everson, Gregory T.
    Forns, Xavier
    Mutimer, David
    Manns, Michael P.
    Reddy, K. Rajender
    Flamm, Steven L.
    Denning, Jill
    Arterburn, Sarah
    Brandt-Sarif, Theo
    Pang, Phil
    McHutchison, John G.
    Afdhal, Nezam H.
    Charlton, Michael R.
    Samuel, Didier
    Gane, Edward
    TRANSPLANTATION, 2015, 99 : 101 - 101
  • [42] Effectiveness of 12 week ledipasvir/sofosbuvir and predictors of treatment failure in patients with hepatitis C
    Carlos del Rio-Valencia, Juan
    Asensi-Diez, Rocio
    Tamayo-Bermejo, Rocio
    Munoz-Castillo, Isabel
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019, 32 (04) : 296 - 302
  • [43] Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation
    Ciesek, S.
    Proske, V.
    Otto, B.
    Pischke, S.
    Costa, R.
    Luethgehetmann, M.
    Polywka, S.
    Klempnauer, J.
    Nashan, B.
    Manns, M. P.
    von Hahn, T.
    Lohse, A. W.
    Wedemeyer, H.
    Mix, H.
    Sterneck, M.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (03) : 326 - 332
  • [44] Effectiveness of Sofosbuvir/Ledipasvir and Sofosbuvir/Simeprevir for the Treatment of Hepatitis C Genotype-1: Real World Analysis
    Abdulameer, Ahmed
    Leff, Phillip
    Joshi, Kartik
    Hepner, Ashley
    Moore, Anne
    Arendt, Karen
    Reynolds, Justin
    Gish, Robert
    Manch, Richard
    Kohli, Anita
    HEPATOLOGY, 2016, 64 : 989A - 990A
  • [45] Treatment of hepatitis C virus recurrence after transplantation with sofosbuvir/ledipasvir: The role of ribavirin
    Globke, Brigitta
    Raschzok, Nathanael
    Teegen, Eva-Maria
    Pratschke, Johann
    Schott, Eckart
    Eurich, Dennis
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (01)
  • [46] Sexual Dysfunction in a Patient Taking Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C: A Case Report
    Lenz, Destin U.
    Crutcher, Effie L.
    Greene, Elisa M.
    JOURNAL OF PHARMACY PRACTICE, 2019, 32 (02) : 231 - 235
  • [47] Aggressive erosive lichen planus associated with hepatitis C responding to sofosbuvir/ledipasvir treatment
    Morgado-Carrasco, Daniel
    Combalia, Andrea
    Fusta-Novell, Xavier
    Manuel Mascaro, Jose, Jr.
    Iranzo, Pilar
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2019, 85 (03) : 326 - 329
  • [48] Identification of Predictors for Treatment Failure in Hepatitis C Virus Patients Treated With Ledipasvir and Sofosbuvir
    Jansen, Jeffrey W.
    Powderly, Gillian M.
    Linneman, Travis W.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (07) : 543 - 547
  • [49] Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin
    Maria Pilar Ballester-Ferré
    Fernando Martínez
    Natalia Garcia-Gimeno
    Francisco Mora
    Miguel A Serra
    World Journal of Hepatology, 2017, (03) : 161 - 166
  • [50] LEDIPASVIR/SOFOSBUVIR WITH RIBAVIRIN FOR THE TREATMENT OF FIBROSING CHOLESTATIC HEPATITIS C AFTER LIVER TRANSPLANTATION
    Mutimer, David
    Forns, Xavier
    Manns, Michael
    Reddy, K. Rajender
    Everson, Gregory T.
    Flamm, Steven L.
    Denning, Jill
    Arterburn, Sarah
    Brandt-Sarif, Theo
    Pang, Phillip S.
    Mchutchison, John G.
    Afdhal, Nezam
    Charlton, Michael
    Samuel, Didier
    Gane, Edward
    TRANSPLANT INTERNATIONAL, 2015, 28 : 235 - 235
12345